National recognition and appreciation for Telangana State’s efforts to eradicate malaria in the last six years between 2015 and 2021 have been given to the State by the National Framework for Malaria Elimination in India (NFMEI) initiative, administered by the National Vector Borne Disease Control Programme (NVBDCP), Director General of Health Services (DGHS), Ministry of Health & Family Welfare (MOHFW), New Delhi.
As a result of untiring efforts made to eradicate malaria, MOHFW’s Director General of Health Services has declared Telangana Category-1 in malaria elimination, senior health officials here say. Telangana had been categorized as a Category-2 state before.
In a Category-2 state, the annual parasite incidence is less than 1 per 1000 populations at risk, however, some districts report an API of at least 1 per 1000 populations at risk. There are states in category-1 that have entered the elimination phase of malaria, including wards with APIs of less than 1 case per 1000 at-risk populations.
ALSO READ: Adult Malaria Patients Have High Levels of IgA Antibodies; Study
The MOHFW invites the Telangana Department of Health, Medical and Family Welfare, to accept the special award for the best-performing state in India in eliminating the disease on upcoming World Malaria Day on April 25. Health Minister T Harish Rao congratulated the State Health Department on achieving the goal.
Vaccines to fight Covid & malaria to be developed by Sapigen
Sapigen Biologix Private Limited, promoted by Dr Krishna M Ella, founder of Bharat Biotech, has signed a contract with the technology development board (TDB) of the Union ministry of science and technology for the development and commercialisation of two vaccines developed by Bharat Biotech – intranasal vaccines against Covid-19 and malaria (RTS, S).
The Union ministry of science and technology stated that Sapigen aims to produce approximately 100 million doses of the intranasal Covid-19 vaccine annually by April 2023 and 15 million doses of the malaria vaccine by the end of April 2025. For the first time, both vaccines will be commercially produced.
(This story has been sourced from a third-party syndicated feed, agencies. Raavi Media accepts no responsibility or liability for the dependability, trustworthiness, reliability, and data of the text. Raavi Media management/ythisnews.com reserves the sole right to alter, delete or remove (without notice) the content at its absolute discretion for any reason whatsoever.)
